Enjoy complimentary customisation on priority with our Enterprise License!
The global pharyngeal cancer therapeutics market size will grow by USD 761.06 million during 2019-2023. This market report provides a detailed analysis of the market by product (targeted therapy and chemotherapy) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including AstraZeneca Plc, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Mylan NV, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.
Key Insights on Pharyngeal Cancer Therapeutics Market - Global Forecast 2019-2023
Browse TOC and LoE with selected illustrations and example pages of Pharyngeal Cancer Therapeutics Market
Market vendors are focusing on the development of novel therapeutics with limited side effects to fulfill the vast unmet need for approved targeted therapy drugs for the treatment of pharyngeal cancer. For instance, TECENTRIQ (atezolizumab), a PD-L1 monoclonal antibody developed by Roche, is being tested in patients with adjuvant SCCHN to prevent cancer immune evasion. Similarly, Merck is developing BAVENCIO (avelumab), an anti-PD-L1 molecule for the treatment of locally advanced SCCHN. AstraZeneca is also conducting clinical trials of durvalumab, a PD-L1 molecule in combination with different drugs. The expected approvals of these late-stage molecules will fuel the growth of the pharyngeal cancer therapeutics market during the next five years.
The pharyngeal cancer therapeutics market forecast highlights the presence of high-risk factors for the disease as another factor driving market growth. Some of the significant risk factors for pharyngeal cancer include the extended use of tobacco, excessive alcohol consumption, increasing viral infections, and occupational hazards. Tobacco smoke contains carcinogens that can damage DNA and develop unusual cells leading to cancer. Alcohol abuse and its combination with tobacco further increase the risk of developing pharyngeal cancer. Also, individuals exposed to certain chemicals, dust, and fumes in their working environments, such as high-dose radiation environments and wood, metal, leather, textile, and petroleum industries have high chances of developing pharyngeal cancer. Such factors are expected to increase the prevalence of pharyngeal cancer and consequently boost the growth of the pharyngeal cancer therapeutics market at a CAGR of over 6% during the forecast period.
The global market is fragmented. To help clients improve their market position, this report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this pharyngeal cancer therapeutics market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the future growth opportunities.
The report offers a detailed analysis of several leading pharyngeal cancer therapeutics companies, including:
The targeted therapy segment will account for the highest pharyngeal cancer therapeutics market share. The expected approval of late-stage molecules and the development of novel targeted therapies are some of the factors driving the growth of the pharyngeal cancer therapeutics market in this segment. This market research report provides an accurate prediction of the contribution of all the segments to the growth of the pharyngeal cancer therapeutics market size.
With a complete study of the growth opportunities for companies, it has been identified that North America will account for the highest share of the pharyngeal cancer therapeutics market throughout the forecast period. The high prevalence of pharyngeal cancer and recent product approvals are contributing to the pharyngeal cancer therapeutics market growth in this region.
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.